United States Direct-To-Consumer Genetic Testing Market is expected to grow at a significant rate during the forecast period, 2024-2028.
Genetic testing refers to medical procedures that examine alterations in genes, chromosomes, or proteins in an effort to either confirm or disprove the existence of a genetic disorder or to estimate a person's propensity to do so. Through direct-to-consumer genetic testing, customers may be able to receive genetic tests with little or no participation from a third-party healthcare professional. Online or printed advertisements are used to offer direct-to-consumer genetic testing kits to potential customers. DTC genetic testing became found at in the early 2000s, enabling consumers to collect genetic data without a doctor's assistance. The exams can be purchased offline or online through distribution outlets.
Rising Demand for Personalized Direct-To-Consumer Genetic Testing Services Fuel Market Expansion
The statistics of the direct-to-consumer genetic testing market will profit from the pharmacogenetics field's rising popularity. One well-known use of gene-based personalization is in the field of pharmacogenetics, in which genetic variations determine the selection of a drug therapy that support the growth of a company. Furthermore, the evaluation and control of individualized tests is done through consumer comprehension. The service provider gives descriptive data on the test's analytic and clinical validity, which raises industry demand. Additionally, the cost of these customized testing is lower than that of conventional genetic examinations. Moreover, findings from customized direct-to-consumer genetic tests can be promptly acquired using easy-to-use, non-invasive techniques. The aforementioned factors are anticipated to increase the direct-to-consumer genetic testing market share overall.
Rising Public Awareness Regarding Direct-To-Consumer (DTC) Genetic Testing is Driving Market Expansion
High Cost of DTC Kits is Hampering the Growth of the US Direct-To-Consumer (DTC) Genetic Testing Market
High cost of DTC genetic testing services is limiting the growth of the US Direct-To-Consumer Genetic testing market. Various manufacturers are focusing on product advancement & innovation, and the integration of next-generation technologies to launch high-end direct-to-consumer tests, leading to high investment in manufacturing facilities along with high product prices. For instance, based on the complexity of the test and the severity of the disease, and the cost of direct-to-consumer genetic tests varies form USD 100 to USD 3,000. Hence, the demand for genetic services across middle-income and developed regions in the United States is anticipated to limit the growth of the market.
Market Segmentation
United States Direct-To-Consumer Genetic Testing Market is segmented based on
Market players
Ancestry.com, LLC, Helix OpCo LLC, MyHeritage Ltd., Living DNA, and Direct Laboratory Services, LLC are the major players operating in the United States Direct-to-Consumer Genetic Testing Market.
Attribute | Details |
Base Year | 2022 |
Historic Data | 2018 – 2021 |
Estimated Year | 2023 |
Forecast Period | 2024 – 2028 |
Quantitative Units | Revenue in USD Million and CAGR for 2018-2022 and 2023-2028 |
Report coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments covered | By Test Type By Technology By Sample By Distribution Channel |
Regional scope | North-East, Mid-West, West, South |
Key companies profiled | Ancestry.com, LLC, Helix OpCo LLC, MyHeritage Ltd., Living DNA, Direct Laboratory Services, LLC |
Customization scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |